All News

Biogennix Names Michael Roux General Manager

January 08, 2019  IRVINE, Calif.–(BUSINESS WIRE)–Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft substitutes used for bone fusion procedures, has named Michael Roux its new General Manager. With nearly three decades of successful technology and medical device industry experience, Roux most recently led Product Management at Glidewell Laboratories, a leading dental …

Integra LifeSciences Announces Preliminary Fourth Quarter 2018 Financial Results

PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited preliminary fourth quarter 2018 financial results. The company expects reported revenue for the fourth quarter of 2018 to be at the higher end of its previous guidance range of $378 million to $383 …

Orthofix Announces Preliminary 2018 Fourth Quarter and Full Year Net Sales Results

January 08, 2019 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX) today announced preliminary unaudited fourth quarter 2018 net sales of approximately $121 million. These preliminary results represent reported sales growth of 3.5% and constant currency sales growth of 4.3% over the fourth quarter 2017. For the full year 2018, preliminary unaudited net sales were approximately $453 …

SpinalCyte, LLC Announces New International Patent

January 08, 2019 SAN FRANCISCO–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced at the JPMorgan Healthcare Conference the issuance of a new Australian patent. The company’s industry leading intellectual property portfolio in spine treatments for its lead product, CybroCell, now includes …

Integra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System

PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has signed a license and development agreement with Consortium of Focused Orthopedists, LLC (CFO), for a short stem and stemless shoulder system.This is a key addition to Integra’s Extremity Orthopedics portfolio in a fast-growing segment …

Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure

MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced that the Centers for Medicare & Medicaid Services (CMS) has established Healthcare Common Procedure Coding System (HCPCS) codes C9752 and C9753 for the Intracept Procedure effective January 1, 2019. The …

Spineology Provides Duo™ System Commercial and Post-Market Update

January 07, 2019 ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce that over 125 lateral interbody fusion cases have been successfully completed using its unique Duo™ Lumbar Interbody Fusion System. The Duo System features the only implant on the market that combines PEEK, titanium, and graft containment mesh …

VGI Medical Engages Ortho Spine Partners (OSP) to lead US Commercialization Efforts

January 8, 2019 Largo, FL – VGI Medical is dedicated to creating the next generation of spinal implants and procedures to improve the quality of life for its patients. To further advance the adoption of its disruptive technologies, VGI Medical has engaged OSP, formerly known as Ortho Sales Partners, to lead the strategy and execution …

OrthoPediatrics Corp. Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018

WARSAW, Ind., Jan. 07, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today its preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2018. Preliminary unaudited fourth quarter 2018 revenue is expected to be in the range of $14.5 million to …

Wright Medical Group N.V. Announces Organizational Changes to Further Drive Long-Term Growth and Profitability

AMSTERDAM, The Netherlands, Jan. 07, 2019 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ: WMGI) today announced organizational changes to further drive the company’s long-term growth and profitability, which support its vision to be the first choice in Extremities and Biologics. Robert Palmisano, president and chief executive officer, stated, “Wright Medical is quickly becoming a …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1